Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids. ✅
The British journal of nutrition (Br J Nutr ) Vol: 88 Suppl 1 Issue Pages: S95-9 Pub: 2002 Sep Epub: Authors Bomba A , Nemcová R , Gancarcíková S , Herich R , Guba P , Mudronová D , |
|
|
Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats. ✅
Go to Publication ✅
The British journal of nutrition (Br J Nutr ) Vol: 108 Issue 9 Pages: 1633-43 Pub: 2012 Nov 14 Epub: 2012 Jan 16 Authors Koleva PT , Valcheva RS , Sun X , Gänzle MG , Dieleman LA , |
|
|
Chemically defined diet alters the protective properties of fructo-oligosaccharides and isomalto-oligosaccharides in HLA-B27 transgenic rats. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 9 Issue 11 Pages: e111717 Pub: 2014 Epub: 2014 Nov 4 Authors Koleva P , Ketabi A , Valcheva R , Gänzle MG , Dieleman LA , |
|
|
Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 11789 Pub: 2017 Sep 18 Epub: 2017 Sep 18 Authors Liu F , Li P , Chen M , Luo Y , Prabhakar M , Zheng H , He Y , Qi Q , Long H , Zhang Y , Sheng H , Zhou H , |
|
|
Oligofructose as an adjunct in treatment of diabetes in NOD mice. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 37627 Pub: 2016 Nov 22 Epub: 2016 Nov 22 Authors Chan C , Hyslop CM , Shrivastava V , Ochoa A , Reimer RA , Huang C , |
|
|
Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosaccharide as selective substrate. ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: 85 Issue 4 Pages: 769-77 Pub: 1998 Oct Epub: Authors Sghir A , Chow JM , Mackie RI , |
|
|
Utilization of diverse oligosaccharides for growth by Bifidobacterium and Lactobacillus species and their in vitro co-cultivation characteristics. ✅
Go to Publication ✅
International microbiology : the official journal of the Spanish Society for Microbiology (Int Microbiol ) Vol: Issue Pages: Pub: 2023 Nov 9 Epub: 2023 Nov 9 Authors Dong Y , Han M , Fei T , Liu H , Gai Z , |
|
|
Gut microbiome supplementation as therapy for metabolic syndrome. ✅
Go to Publication ✅
World journal of diabetes (World J Diabetes ) Vol: 14 Issue 10 Pages: 1502-1513 Pub: 2023 Oct 15 Epub: Authors Antony MA , Chowdhury A , Edem D , Raj R , Nain P , Joglekar M , Verma V , Kant R , |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.